Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3323541
Max Phase: Preclinical
Molecular Formula: C14H14N6O2S2
Molecular Weight: 362.44
Molecule Type: Small molecule
Associated Items:
ID: ALA3323541
Max Phase: Preclinical
Molecular Formula: C14H14N6O2S2
Molecular Weight: 362.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nn1c(Cc2cccs2)nn(CC(=O)N/N=C/c2cccs2)c1=O
Standard InChI: InChI=1S/C14H14N6O2S2/c15-20-12(7-10-3-1-5-23-10)18-19(14(20)22)9-13(21)17-16-8-11-4-2-6-24-11/h1-6,8H,7,9,15H2,(H,17,21)/b16-8+
Standard InChI Key: BZWMZMYYPPLEBZ-LZYBPNLTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 362.44 | Molecular Weight (Monoisotopic): 362.0620 | AlogP: 0.62 | #Rotatable Bonds: 6 |
Polar Surface Area: 107.30 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.62 | CX Basic pKa: 2.31 | CX LogP: 1.84 | CX LogD: 1.84 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.38 | Np Likeness Score: -2.79 |
1. Ünver Y, Sancak K, Çelik F, Birinci E, Küçük M, Soylu S, Burnaz NA.. (2014) New thiophene-1,2,4-triazole-5(3)-ones: highly bioactive thiosemicarbazides, structures of Schiff bases and triazole-thiols., 84 [PMID:25063946] [10.1016/j.ejmech.2014.01.014] |
Source(1):